Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

1.

Trimerization of apolipoprotein A-I retards plasma clearance and preserves antiatherosclerotic properties.

Graversen JH, Laurberg JM, Andersen MH, Falk E, Nieland J, Christensen J, Etzerodt M, Thøgersen HC, Moestrup SK.

J Cardiovasc Pharmacol. 2008 Feb;51(2):170-7. doi: 10.1097/FJC.0b013e31815ed0b9.

PMID:
18287885
[PubMed - indexed for MEDLINE]
2.

Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.

Moore RE, Navab M, Millar JS, Zimetti F, Hama S, Rothblat GH, Rader DJ.

Circ Res. 2005 Oct 14;97(8):763-71. Epub 2005 Sep 8.

PMID:
16151025
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.

Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L, Beaudet A, Chan L.

Circulation. 2003 Jun 3;107(21):2726-32. Epub 2003 May 12.

PMID:
12742997
[PubMed - indexed for MEDLINE]
Free Article
5.

Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice.

Pedersen TX, Bro S, Andersen MH, Etzerodt M, Jauhiainen M, Moestrup S, Nielsen LB.

Atherosclerosis. 2009 Feb;202(2):372-81. doi: 10.1016/j.atherosclerosis.2008.04.041. Epub 2008 May 1.

PMID:
18489910
[PubMed - indexed for MEDLINE]
6.

Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.

Kitayama K, Nishizawa T, Abe K, Wakabayashi K, Oda T, Inaba T, Amemiya Y.

J Pharm Pharmacol. 2006 Dec;58(12):1629-38.

PMID:
17331327
[PubMed - indexed for MEDLINE]
7.

Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient mice.

Kawashiri MA, Zhang Y, Puré E, Rader DJ.

Atherosclerosis. 2002 Nov;165(1):15-22.

PMID:
12208466
[PubMed - indexed for MEDLINE]
8.

Arg123-Tyr166 domain of human ApoA-I is critical for HDL-mediated inhibition of macrophage homing and early atherosclerosis in mice.

Holvoet P, Peeters K, Lund-Katz S, Mertens A, Verhamme P, Quarck R, Stengel D, Lox M, Deridder E, Bernar H, Nickel M, Theilmeier G, Ninio E, Phillips MC.

Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1977-83.

PMID:
11742873
[PubMed - indexed for MEDLINE]
Free Article
9.

Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.

Chroni A, Kan HY, Shkodrani A, Liu T, Zannis VI.

Biochemistry. 2005 Mar 15;44(10):4108-17.

PMID:
15751988
[PubMed - indexed for MEDLINE]
10.

Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.

Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, Yang F, Durante W, Chan L, Schafer AI, Pownall HJ, Yang X, Wang H.

Circ Res. 2006 Sep 15;99(6):598-606. Epub 2006 Aug 24.

PMID:
16931800
[PubMed - indexed for MEDLINE]
Free Article
11.

Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor.

Moore RE, Kawashiri MA, Kitajima K, Secreto A, Millar JS, Pratico D, Rader DJ.

Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1914-20. Epub 2003 Aug 21.

PMID:
12933536
[PubMed - indexed for MEDLINE]
Free Article
12.

Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice.

Christoffersen C, Jauhiainen M, Moser M, Porse B, Ehnholm C, Boesl M, Dahlbäck B, Nielsen LB.

J Biol Chem. 2008 Jan 25;283(4):1839-47. Epub 2007 Nov 15.

PMID:
18006500
[PubMed - indexed for MEDLINE]
Free Article
13.

Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice.

Parastatidis I, Thomson L, Fries DM, Moore RE, Tohyama J, Fu X, Hazen SL, Heijnen HF, Dennehy MK, Liebler DC, Rader DJ, Ischiropoulos H.

Circ Res. 2007 Aug 17;101(4):368-76. Epub 2007 Jul 5.

PMID:
17615369
[PubMed - indexed for MEDLINE]
Free Article
14.

Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution.

Reschly EJ, Sorci-Thomas MG, Davidson WS, Meredith SC, Reardon CA, Getz GS.

J Biol Chem. 2002 Mar 22;277(12):9645-54. Epub 2001 Dec 14.

PMID:
11744719
[PubMed - indexed for MEDLINE]
Free Article
15.

LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.

Koukos G, Chroni A, Duka A, Kardassis D, Zannis VI.

Biochemistry. 2007 Sep 18;46(37):10713-21. Epub 2007 Aug 21.

PMID:
17711302
[PubMed - indexed for MEDLINE]
16.

Proteolytic degradation and impaired secretion of an apolipoprotein A-I mutant associated with dominantly inherited hypoalphalipoproteinemia.

McManus DC, Scott BR, Franklin V, Sparks DL, Marcel YL.

J Biol Chem. 2001 Jun 15;276(24):21292-302. Epub 2001 Apr 5.

PMID:
11292828
[PubMed - indexed for MEDLINE]
Free Article
17.

Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent.

Lebherz C, Sanmiguel J, Wilson JM, Rader DJ.

Cardiovasc Diabetol. 2007 May 2;6:15.

PMID:
17475009
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Clearance of cationized LDL cholesterol from a muscle depot is not enhanced in human apolipoprotein A-IV transgenic mice.

Stein Y, Stein O, Duverger N, Halperin G, Dabach Y, Hollander G, Ben-Naim M.

Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):179-84.

PMID:
10634815
[PubMed - indexed for MEDLINE]
Free Article
19.

The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.

Rosenblat M, Gaidukov L, Khersonsky O, Vaya J, Oren R, Tawfik DS, Aviram M.

J Biol Chem. 2006 Mar 17;281(11):7657-65. Epub 2006 Jan 10.

PMID:
16407304
[PubMed - indexed for MEDLINE]
Free Article
20.

Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice.

Moerland M, Samyn H, van Gent T, Jauhiainen M, Metso J, van Haperen R, Grosveld F, van Tol A, de Crom R.

J Lipid Res. 2007 Dec;48(12):2622-31. Epub 2007 Aug 29.

PMID:
17761633
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk